BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1404 related articles for article (PubMed ID: 17136045)

  • 21. CTLA-4 control over Foxp3+ regulatory T cell function.
    Wing K; Onishi Y; Prieto-Martin P; Yamaguchi T; Miyara M; Fehervari Z; Nomura T; Sakaguchi S
    Science; 2008 Oct; 322(5899):271-5. PubMed ID: 18845758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases.
    Valencia X; Lipsky PE
    Nat Clin Pract Rheumatol; 2007 Nov; 3(11):619-26. PubMed ID: 17968332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tryptophan catabolism generates autoimmune-preventive regulatory T cells.
    Fallarino F; Grohmann U; You S; McGrath BC; Cavener DR; Vacca C; Orabona C; Bianchi R; Belladonna ML; Volpi C; Fioretti MC; Puccetti P
    Transpl Immunol; 2006 Dec; 17(1):58-60. PubMed ID: 17157218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Foxp3(+) Treg cell activity reduces dendritic cell co-stimulatory molecule expression in aged mice.
    Chiu BC; Stolberg VR; Zhang H; Chensue SW
    Mech Ageing Dev; 2007; 128(11-12):618-27. PubMed ID: 17961632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of type 1 diabetes by CD4+Foxp3+ regulatory T cells: lessons from mouse models and implications for human disease.
    Sgouroudis E; Piccirillo CA
    Diabetes Metab Res Rev; 2009 Mar; 25(3):208-18. PubMed ID: 19214972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice.
    Lahl K; Mayer CT; Bopp T; Huehn J; Loddenkemper C; Eberl G; Wirnsberger G; Dornmair K; Geffers R; Schmitt E; Buer J; Sparwasser T
    J Immunol; 2009 Nov; 183(9):5662-72. PubMed ID: 19812199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limited role of CD4+Foxp3+ regulatory T cells in the control of experimental cerebral malaria.
    Steeg C; Adler G; Sparwasser T; Fleischer B; Jacobs T
    J Immunol; 2009 Dec; 183(11):7014-22. PubMed ID: 19890049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T(reg) cells: collection, processing, storage and clinical use.
    Daniele N; Scerpa MC; Landi F; Caniglia M; Miele MJ; Locatelli F; Isacchi G; Zinno F
    Pathol Res Pract; 2011 Apr; 207(4):209-15. PubMed ID: 21397410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mast cells down-regulate CD4+CD25+ T regulatory cell suppressor function via histamine H1 receptor interaction.
    Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW
    J Immunol; 2009 Sep; 183(5):3014-22. PubMed ID: 19667094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reciprocal generation of Th1/Th17 and T(reg) cells by B1 and B2 B cells.
    Zhong X; Gao W; Degauque N; Bai C; Lu Y; Kenny J; Oukka M; Strom TB; Rothstein TL
    Eur J Immunol; 2007 Sep; 37(9):2400-4. PubMed ID: 17683116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
    Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
    J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection.
    Smyk-Pearson S; Golden-Mason L; Klarquist J; Burton JR; Tester IA; Wang CC; Culbertson N; Vandenbark AA; Rosen HR
    J Infect Dis; 2008 Jan; 197(1):46-57. PubMed ID: 18171284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying the cells breaching self-tolerance in autoimmunity.
    Benson RA; Patakas A; Conigliaro P; Rush CM; Garside P; McInnes IB; Brewer JM
    J Immunol; 2010 Jun; 184(11):6378-85. PubMed ID: 20421640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease.
    Lahl K; Loddenkemper C; Drouin C; Freyer J; Arnason J; Eberl G; Hamann A; Wagner H; Huehn J; Sparwasser T
    J Exp Med; 2007 Jan; 204(1):57-63. PubMed ID: 17200412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New tools to identify regulatory T cells.
    Graca L
    Eur J Immunol; 2005 Jun; 35(6):1678-80. PubMed ID: 15902689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cell apoptosis in the maintenance of immune tolerance.
    Chen M; Wang YH; Wang Y; Huang L; Sandoval H; Liu YJ; Wang J
    Science; 2006 Feb; 311(5764):1160-4. PubMed ID: 16497935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advantage of having regulatory T cells requires localized suppression of immune reactions.
    Saeki K; Iwasa Y
    J Theor Biol; 2009 Oct; 260(3):392-401. PubMed ID: 19563814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory T cell development in the absence of functional Foxp3.
    Lin W; Haribhai D; Relland LM; Truong N; Carlson MR; Williams CB; Chatila TA
    Nat Immunol; 2007 Apr; 8(4):359-68. PubMed ID: 17273171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory T-cell physiology and application to treat autoimmunity.
    Tang Q; Bluestone JA
    Immunol Rev; 2006 Aug; 212():217-37. PubMed ID: 16903917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 71.